Loading...
Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial
Rationale: Aspirin-exacerbated respiratory disease is characterized by severe asthma, nonsteroidal antiinflammatory drug hypersensitivity, nasal polyposis, and leukotriene overproduction. Systemic corticosteroid therapy does not completely suppress lifelong aspirin hypersensitivity. Omalizumab effic...
Saved in:
| Published in: | Am J Respir Crit Care Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Thoracic Society
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7301746/ https://ncbi.nlm.nih.gov/pubmed/32142372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201906-1215OC |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|